Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 394,898	$ 170,840	$ 410,553
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	611,025	582,014	574,813
Loss on early retirement of debt	0	921	2,513
Gain on sale of operating properties	(260,910)	(43,806)	(225,416)
Impairment associated with land development activities	12,916	40,988	0
Share-based compensation	16,959	15,166	14,512
Net change in operating accounts and other	51,733	8,754	17,975
Net cash from operating activities	826,621	774,877	794,950
Cash flows from investing activities
Development and capital improvements, including land	(440,402)	(393,735)	(410,934)
Acquisition of operating properties	(419,226)	0	0
Net proceeds from sales of operating properties	365,906	114,474	290,663
Increase in non-real estate assets	(2,445)	(3,800)	(5,597)
Other	(3,372)	(2,169)	(1,259)
Net cash from investing activities	(499,539)	(285,230)	(127,127)
Cash flows from financing activities
Borrowings on unsecured revolving credit facility	588,000	586,000	1,335,000
Repayments on unsecured revolving credit facility	(766,000)	(408,000)	(1,377,000)
Proceeds from (Repayments of) Commercial Paper	588,108	0	0
Repayment of notes payable, including prepayment penalties	0	(800,000)	(437,749)
Proceeds from notes payable	0	395,952	498,235
Distributions to common shareholders and non-controlling interests	(460,950)	(450,965)	(434,875)
Payment of deferred financing costs	(2,386)	(2,878)	(3,114)
Repurchase of common shares	(270,654)	(49,997)	0
Other	1,833	4,403	2,289
Net cash from financing activities	(322,049)	(725,485)	(417,214)
Net increase (decrease) in cash, cash equivalents, and restricted cash	5,033	(235,838)	250,609
Cash, cash equivalents, and restricted cash, beginning of year	32,209	268,047	17,438
Cash, cash equivalents, and restricted cash, end of year	37,242	32,209	268,047
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets [Abstract]
Cash and cash equivalents	25,203	21,045	259,686
Restricted cash	12,039	11,164	8,361
Total cash, cash equivalents, and restricted cash	37,242	32,209	268,047
Supplemental information
Cash paid for interest, net of interest capitalized	139,625	129,637	128,870
Cash paid for income taxes	3,482	2,816	3,591
Supplemental schedule of noncash investing and financing activities
Distributions declared but not paid	114,971	113,549	110,427
Value of shares issued under benefit plans, net of cancellations	27,542	25,134	24,850
Accrual associated with construction and capital expenditures	31,487	24,097	23,706
Right-of-use assets obtained in exchange for the use of new operating lease liabilities	$ 22,005	$ 0	$ 0